VEGFC and colonic neoplasm: IRF-2 in exosomes derived from colon cancer lines promotes the proliferation of lymphatic endothelial cells and the formation of the lymphatic network in the sentinel lymph node, increasing the frequency of F4/80+ macrophages and promoting Vascular Endothelial Growth Factor C (VEGFC) secretion [63].